elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38857067-84F10354-38B6-4717-B9B8-288217F33684
Q38857067-84F10354-38B6-4717-B9B8-288217F33684
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38857067-84F10354-38B6-4717-B9B8-288217F33684
Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML.
P2860
Q38857067-84F10354-38B6-4717-B9B8-288217F33684
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38857067-84F10354-38B6-4717-B9B8-288217F33684
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0e2959faebb7de532c51a672e0c1e2e28e00df8d
P2860
Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed/refractory B-cell malignancies.